نتایج جستجو برای: methylphenidate mph

تعداد نتایج: 6344  

Background Methylphenidate (MPH) is commonly prescribed for children who have been diagnosed with attention deficit hyperactivity disorder (ADHD); however, the action mechanisms of methylphenidate have not been fully elucidated. Studies have shown a relationship between apoptosis signaling pathways and psychiatric disorders, as well as therapeutic targets for such disorders. So, we examined the...

Background: Methylphenidate (MPH) has been used to induce emergence from general anesthesia. OBJECTIVES:  The objective of the present study was to evaluate the effect of MPH on recovery from propofol and ketamine anesthesia in dogs. METHODS: Six healthy male mix-breed dogs weighing 21.9 ± 3.9 kg were used in a randomized crossover design. Thirty minutes after premedication with acepromazine (0...

ژورنال: پیاورد سلامت 2019
Akbari, Ghasem, Khalilzadeh, Emad , Kianifard, Davoud, Zakipour, Parastoo ,

Background and Aim: Methylphenidate (MPH) is one of the commonly used drugs in the treatment of hyperactivity disorder in children. The use of MPH has been associated with increased activity of the central nervous system so may lead to the abuse of this compound. Nicotine is one of the compounds available in a wide range of people in various forms. The negative effects of nicotine on pituitary-...

Journal: :Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011
Sabrina Mioranzza Marcelo S. Costa Paulo Henrique S. Botton Ana Paula Ardais Vanessa Lague Matte Janaina Espinosa Diogo O. Souza Lisiane O. Porciúncula

Methylphenidate (MPH) is the preferred treatment used for attention-deficit/hyperactivity disorder (ADHD). Recently, misuse for MPH due to its apparent cognitive enhancer properties has been reported. Adenosine is a neuromodulator known to exert influence on the dopaminergic neurotransmission, which is the main pharmacological target of MPH. We have reported that an overdosage of MPH up-regulat...

Journal: :Cukurova Medical Journal 2022

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental commencing before the age of 12 years and characterized by developmentally inappropriate inattention, hyperactivity, and/or impulsivity symptoms. Stimulants such as methylphenidate (MPH) are used first-line therapy for children with ADHD. Psychostimulants may be associated vascular problems. Raynaud’s phenomenon (RP) periph...

2013
Tangunu Fosi Maria T Lax-Pericall Rod C Scott Brian G Neville Sarah E Aylett

PURPOSE To establish the efficacy and safety of methylphenidate (MPH) treatment for attention deficit hyperactivity disorder (ADHD) in a group of children and young people with learning disability and severe epilepsy. METHODS This retrospective study systematically reviewed the case notes of all patients treated with methylphenidate (MPH) for Diagnostic and Statistical Manual of Mental Disord...

Journal: :Physiology & Behavior 2014
Bruno Garcia Montagnini Luiza Sienna Silva Alice Hartmann dos Santos Janete Aparecida Anselmo-Franci Glaura Scantamburlo Alves Fernandes Suzana de Fátima Paccola Mesquita Daniela Cristina Ceccatto Gerardin

Methylphenidate (MPH) is a psychostimulant drug which acts by blocking the dopamine and norepinephrine transporters and is the main drug used to treat attention deficit hyperactivity disorder in children and adolescents. During puberty, changes in neurotransmitter systems (including dopaminergic system) are engaged on the release of gonadal hormones and the development of cephalic structures re...

Journal: :iranian journal of medical sciences 0
robabeh soleimani department of psychiatry, cognitive and addiction research center, shafa hospital, guilan university of medical sciences, guilan, iran maryam kousha department of child psychiatry, shafa hospital, guilan university of medical sciences, guilan, iran; homa zarrabi department of psychiatry, shafa hospital, guilan university of medical sciences, guilan, iran seyede mahnaz tavafzadeh-haghi department of psychiatry, shafa hospital, guilan university of medical sciences, guilan, iran mir mohammad jalali school of medicine, guilan university of medical sciences, guilan, iran

background: children with attention deficit hyperactivity disorder/developmental coordination disorder (adhd/dcd) suffer from problems associated with gross and fine motor skills. there is no effective pharmacological therapy for such patients. we aimed to assess the impact of methylphenidate (mph) on motor performance of children with adhd/dcd. methods: in this double-blind placebo-controlled,...

Journal: :iranian journal of psychiatry 0
mohammadreza mohammadi psychiatry and psychology research center, roozbeh hospital, tehran university of medical sciences, tehran, iran soleiman mohammadzadeh department of psychiatry, kurdistan university of medical sciences shahin akhondzadeh psychiatry and psychology research center, roozbeh hospital, tehran university of medical sciences, tehran, iran

objectives : the aim of this randomized clinical trial was to assess the efficacy of memantine versus methylphenidate in the treatment of children with attention deficit hyperactivity disorder. method : forty participants (34 boys and 6 girls) aged 6-11 who were diagnosed with attention deficit hyperactivity disorder based on (dsm-iv-tr) criteria were selected for this study. the participants w...

2013
Jasmin Bartl Takatoshi Mori Peter Riederer Hiroki Ozawa Edna Grünblatt

BACKGROUND The psychostimulant methylphenidate (MPH) is the first choice of drug treatment in Attention-Deficit/Hyperactivity Disorder (ADHD). Since therapy often begins at a time when the brain is still developing and the long-term consequences of MPH are still not fully clarified, we examined the influences of an acute treatment with MPH on the differentiation and proliferation of murine neur...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید